Humira

Humira is an immunosuppressant used for the treatment of rheumatoid arthritis, juvenile arthritis and Crohn’s Disease. The Food and Drug Administration approved it for the commercial use. Common side effects caused by Humira are flu symptoms, fever with chills, dry cough, weight loss, body ache and fever. Patients using Humira are at a higher risk of developing severe side effects including infections that may lead to hospitalization and even death. As Humira affects the functioning of immunity system, it decreases the ability of the body to fight infections like opportunistic infections and tuberculosis. Use of Humira blocks TNF (tumor necrosis factor), thus causing lymphomas including other malignancies.

Recently, the U.S. Food and Drug Administration announced Black Box Label Warning for Humira. Black box warning label is the harshest warning label given by FDA to any drug. This label is given only after studies and researches established that a drug is hazardous to an individual’s life.